Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Drug-Induced Liver Injury and SLCO1B1[original query] |
|---|
| Polymorphisms in drug transporter genes (ABCB1, SLCO1B1 and ABCC2) and hepatitis induced by antituberculosis drugs. Tuberculosis (Edinburgh, Scotland) 2012 Jan 92 (1): 100-4. Kim Sang-Hoon, Kim Sang-Heon, Lee Jae-Hyung, Lee Byoung-Hoon, Kim Youn-Seup, Park Jae-Seuk, Jee Young-K |
| Association of CYP2C9*2 with bosentan-induced liver injury. Clinical pharmacology and therapeutics 2013 Dec 94 (6): 678-86. Markova S M, De Marco T, Bendjilali N, Kobashigawa E A, Mefford J, Sodhi J, Le H, Zhang C, Halladay J, Rettie A E, Khojasteh C, McGlothlin D, Wu A H B, Hsueh W-C, Witte J S, Schwartz J B, Kroetz D |
| [Study on polymorphisms of genes with susceptibility to drug induced liver injury in a cohort receiving anti-tuberculosis treatment]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 2016 Jul 37 (7): 925-9. Chen R, Wang J, Tang S W, Lyu X Z, Zhang Y, Wu S S, Xia Y Y, Zhan S |
| Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis. BMJ open 2019 Aug 9 (8): e027940. Yang Seungwon, Hwang Se Jung, Park Jung Yun, Chung Eun Kyoung, Lee Jangik |
| Association between genetic polymorphisms of SLCO1B1 and susceptibility to methimazole-induced liver injury. Basic & clinical pharmacology & toxicology 2019 Jun . Jin Shasha, Li Xuesong, Fan Yujuan, Fan Xiaofang, Dai Yu, Lin Haishu, Cai Weimin, Yang Jialin, Xiang Xiaoqia |
| Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav-Related Liver Injury. Frontiers in pharmacology 2022 6 13 882962. Alshabeeb Mohammad, Alomar Fadhel A, Khan Amj |
| Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors. Hepatology communications 2024 8 8 (9): . Robert J Fontana, Yi-Ju Li, Vincent Chen, David Kleiner, Andrew Stolz, Joe Odin, Raj Vuppalanchi, Jiezhun Gu, Lily Dara, Huiman Barnhart, |
| Integration of genomics, clinical characteristics and baseline biological profiles to predict the risk of liver injury induced by high-dose methotrexate. Frontiers in pharmacology 2024 12 15 1423214. Chenquan Lin, Rui Ma, Xiao Zeng, Bikui Zhang, Ting Cao, Shimeng Jiao, Hui Chen, Yifang He, Mouze Liu, Hualin C |
- Page last reviewed:Feb 1, 2024
- Content source:

